SynCore Biotechnology Co.,Ltd (TPEX:4192)
19.60
+0.30 (1.55%)
Aug 4, 2026, 1:08 PM CST
TPEX:4192 Market Cap
TPEX:4192 has a market cap or net worth of 689.22 million as of August 4, 2026. Its market cap has decreased by -28.86% in one year.
Market Cap
689.22M
Enterprise Value
547.90M
Revenue
27.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
19.60
ChartMarket Cap Chart
Since August 29, 2013, TPEX:4192's market cap has decreased from 3.70B to 689.22M, a decrease of -81.36%. That is a compound annual growth rate of -12.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 689.22M | -21.29% |
| Dec 31, 2025 | 875.60M | -28.55% |
| Dec 31, 2024 | 1.23B | -9.24% |
| Dec 29, 2023 | 1.35B | -53.80% |
| Dec 30, 2022 | 2.92B | -20.00% |
| Dec 30, 2021 | 3.65B | -26.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GeneReach Biotechnology | 956.96M |
| Holy Stone Healthcare | 953.21M |
| TCI GENE | 899.59M |
| Meribank Biotech | 872.42M |
| Taiwan Advance Bio-Pharmaceutical | 799.20M |
| NatureWise Biotech & Medicals | 762.33M |
| BioLASCO Taiwan | 760.68M |
| Neith | 710.20M |